We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SEDG icon
851
SolarEdge
SEDG
$1.3B
$2.53M 0.01%
79,395
+68,586
+635% +$2.69M
2026 Q1
2 quarters
JMKE
852
Jersey Mike's Subs
JMKE
$5.9B
$2.52M 0.01%
+150,000
New +$3.18M
2026 Q3
0 quarters
RUMBW icon
853
RUM Group Warrant
RUMBW
$5.85M
$2.52M 0.01%
1,481,796
-5,357
-0.4% -$9.9K
2024 Q4
7 quarters
XSLLU icon
854
Xsolla SPAC 1 Units
XSLLU
$258M
$2.52M 0.01%
250,000
– –
2026 Q1
2 quarters
APMCU icon
855
AmperCap Acquisition Co Unit
APMCU
$131M
$2.51M 0.01%
250,000
– –
2026 Q2
1 quarter
XBI icon
856
State Street SPDR S&P Biotech ETF
XBI
$9.8B
$2.48M 0.01%
15,700
-116,011
-88% -$18.3M
2025 Q4
3 quarters
AZN icon
857
AstraZeneca
AZN
$277B
$2.46M 0.01%
15,250
-175
-1% -$29.2K
2023 Q1
14 quarters
PCG icon
858
PUT
PG&E
PCG
$30.2B
$2.45M 0.01%
+200,000
New +$3.21M
2026 Q3
0 quarters
APLD icon
859
Applied Digital
APLD
$4.37B
$2.44M 0.01%
100,000
-118,013
-54% -$3.31M
2026 Q2
1 quarter
APLD icon
860
PUT
Applied Digital
APLD
$4.37B
$2.44M 0.01%
+100,000
New +$2.81M
2026 Q3
0 quarters
MOMO icon
861
Hello Group
MOMO
$610M
$2.43M 0.01%
502,512
– –
2024 Q1
10 quarters
AADX icon
862
Applied Aerospace & Defense
AADX
$1.17B
$2.41M 0.01%
200,000
– –
2026 Q2
1 quarter
UTZ icon
863
Utz Brands
UTZ
$1.26B
$2.39M 0.01%
+167,993
New +$2.16M
2026 Q3
0 quarters
TEM icon
864
CALL
Tempus AI
TEM
$11.6B
$2.38M 0.01%
+29,000
New +$1.75M
2026 Q3
0 quarters
IBRX icon
865
PUT
ImmunityBio
IBRX
$7.13B
$2.37M 0.01%
251,400
-9,700
-4% -$77.5K
2023 Q2
13 quarters
ROIV icon
866
Roivant Sciences
ROIV
$28.1B
$2.37M 0.01%
64,835
+30,060
+86% +$1.09M
2024 Q1
10 quarters
NVO icon
867
CALL
Novo Nordisk
NVO
$174B
$2.36M 0.01%
+62,200
New +$2.87M
2026 Q3
0 quarters
NVO icon
868
PUT
Novo Nordisk
NVO
$174B
$2.36M 0.01%
+62,200
New +$2.87M
2026 Q3
0 quarters
KDP icon
869
Keurig Dr Pepper
KDP
$47.6B
$2.36M 0.01%
77,696
+77,694
+3,884,700% +$2.43M
2025 Q1
6 quarters
RVTY icon
870
Revvity
RVTY
$17B
$2.34M 0.01%
+15,310
New +$1.88M
2026 Q3
0 quarters
BOW icon
871
Bowhead Specialty Holdings
BOW
$1.13B
$2.33M 0.01%
+69,015
New +$2.26M
2026 Q3
0 quarters
OGN icon
872
Organon & Co
OGN
$3.66B
$2.33M 0.01%
169,833
-227,009
-57% -$3.1M
2026 Q1
2 quarters
CSHRW icon
873
CoinShares Warrants
CSHRW
$5.61M
$2.32M 0.01%
2,017,620
+200,267
+11% +$171K
2026 Q2
1 quarter
CSR icon
874
Centerspace
CSR
$944M
$2.29M 0.01%
+42,098
New +$2.33M
2026 Q3
0 quarters
IREN icon
875
IREN
IREN
$6.47B
$2.28M 0.01%
55,803
+45,803
+458% +$1.88M
2025 Q3
4 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.